Millions of Americans are not taking their GLP-1 drugs as prescribed

November 13, 2026 n Beth Molen

Summary

Despite the widespread popularity of peptide-based GLP-1 medications for diabetes and weight loss, recent data indicates that millions of Americans are failing to use them as prescribed. Many individuals have instead turned to unapproved versions of these treatments, raising concerns amid the ongoing surge in demand for the drugs.

GLP-1 medications are everywhere these days. The peptide-based drugs are both highly effective and wildly popular for diabetes, weight loss and a growing range of connected chronic health conditions, including cardiovascular disease and obstructive sleep apnea. But, amid the boom, the latest data suggests millions of Americans have turned to unapproved versions and are using the potent drugs in ways…

Source: Read the full story at Ars Technica

Follow Tech & Money Press for daily watchlists and market news

X Facebook Instagram TikTok

Disclaimer: This content is for informational and educational purposes only and is not financial, investment or trading advice. Tech & Money Press is not a registered investment adviser or broker-dealer. Trading stocks, options and crypto involves substantial risk, including the loss of your entire investment. Do your own research and consult a licensed professional before making any financial decision. The authors may hold positions in the securities mentioned. News summaries are written with AI assistance from the original publisher's report and may contain errors; always check the original source. Full disclaimer.